Community Clinical Oncology Program
Research Base Protocol Credit Assignment
Approved, Active, and Closed Protocols

Research Base Cancer Trials Support Unit (CTSU)
qry_Credit_Report_Output_HTML_CTSU
Protocol Number Type of Cancer or Study Intergroup Number Coordinating Center Study Status Closure Date Treatment Credit Cancer Control Credit Followup Credit Followup Years Credit Description
ACOSOG-Z0011 Breast ACOSOG-Z0011 NCCTG CL 12/15/2004 1
0 0
ACOSOG-Z1031 Breast
CTSU AC
1 0 0 0
ACOSOG-Z1041 Breast
CTSU AC
1 0 0 0
ACOSOG-Z9000 Gastrointestinal ACOSOG-Z9000 CTSU CL 9/26/2003 1
0 0
ACOSOG-Z9001 Gastrointestinal ACOSOG-Z9001 CTSU CL 4/18/2007 1
0 0
ACOSOG-Z9031 Other
CTSU CL 2/27/2006 1 0 0 0
C80405 Gastrointestinal C80405 CALGB AC
1 0.3 0 0 0.3 Cancer Control Credit for QOL. Sample size for QOL component is 462 out of the overall study sample of N=2289. QOL component approved 9/19/2007
CALGB-100104 Other CALGB-100104 CALGB AC
1 0 0 0
CALGB-10201 Leukemia, Acute CALGB-10210 CALGB CL 10/20/2006 1 0 0 0
CALGB-140503 Lung Non-Small Cell CALGB-140503 CALGB AC
1 0 0 0
CALGB-30102 Lung CALGB-30102 CALGB CL 12/28/2004 1 0.3 0 0 Cancer Control Credit QOL
CALGB-30610 Lung CALGB-30610 CALGB AC
1 0.5 0 0 0.5 Cancer Control credit for QOL component
CALGB-39801 Lung Non-Small Cell CALGB-39801 CALGB CL 5/31/2002 1
0 0
CALGB-40101 Breast CALGB-40101 CALGB AC
1
0 0
CALGB-40302 Breast CALGB-40302 CALGB AC
1 0 0 0
CALGB-49808 Breast CALGB-49808 CALGB CL 12/15/2002 1
0 0
CALGB-49907 Breast CALGB-49907 CALGB CL 12/29/2006 1 0.2 0 0 Assignment changed to 0.2 CC credits for sites and research base. Original assignment = 0.5 cc credit for QOL to the CALGB Research Base only.
CALGB-50303 Lymphomas CALGB-50303 CALGB AC
1 0 0 0
CALGB-70301 Breast CALGB-70301 CALGB AC
0 0.2 0 0 Credit retroactive to June 1,2005.
CALGB-80101 Gastric CALGB-80101 CALGB AC
1 0 0 0
CALGB-80203 Gastrointestinal CALGB-80203 CALGB CL 1/15/2005 1
0 0 No Cancer Control credit for QOL
CALGB-80303 Gastrointestinal CALGB-80303 CALGB CL 4/14/2006 1 0 0 0
CALGB-90104 Genitourinary CALGB-90104 CALGB CL 7/15/2005 1 0 0 0
CALGB-90106 Other CALGB-90106 CALGB CL 4/1/2005 1 0 0 0
CALGB-90202 Genitourinary CALGB-90202 CALGB AC
1 0 0 0
CALGB-90203 Genitourinary CALGB-90203 CALGB AC
1 0 0 0
CALGB-90206 Genitourinary CALGB-90206 CALGB CL 7/1/2005 1 0 0 0
CALGB-90401 Genitourinary CALGB-90401 CALGB CL 12/21/2007 1 0 0 0
CALGB-9633 Lung Non-Small Cell CALGB-9633 CALGB CL 1/6/2004 1
0 0
CALGB-9840 Breast CALGB-9840 CALGB CL 11/14/2003 1 0 0 0
E1105 Breast E1105 ECOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
E1301 Head and Neck E1301 ECOG CL 12/20/2004 1 0 0 0
E1302 Head and Neck E1302 ECOG AC
1 0.5 0 0 Cancer Control credit for QOL
E1505 Lung Non-Small Cell E1505 ECOG AC
1 0 0 0
E1899 Genitourinary E1899 ECOG CL 12/28/2004 1 0.3 0 0 0.3 Cancer Control Credit for QOL
E1900 Leukemia, Acute E1900 ECOG AC
1 0 0 0
E1A05 Multiple Myeloma E1A05 ECOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
E1A06 Multiple Myeloma E1A06 ECOG AC
1 0.5 0 0 0.5 Cancer Control for QOL component
E1Y03
E1Y03 ECOG AC
0
0 0 No credit assigned
E1Z03 Breast E1Z03 ECOG CL 12/16/2005 0 0.5 0 0 QOL Companion trial to NCIC-MA.27
E2100 Breast E2100 ECOG CL 5/26/2004 1
0 0 No Cancer Control Credit for QOL
E2204 Gastrointestinal E2204 ECOG CL 1/9/2008 1 0 0 0
E2301 Head and Neck
ECOG CL 5/8/2003 1
0 0
E2603 Melanoma E2603 ECOG AC
1 0 0 0
E2804 Genitourinary E2804 ECOG AC
1 0 0 0
E2805 Genitourinary E2805 ECOG AC
1 0 0 0
E2902 Leukemia, Acute E2902 ECOG AC
1
0 0
E3200 Gastrointestinal E3200 ECOG CL 4/28/2003 1
0 0
E3201 Gastrointestinal E3201 ECOG CL 10/28/2005 1 0.5 0 0 0.5 Cancer Control credit for QOL
E3598 Lung Non-Small Cell E3598 ECOG CL 10/26/2006 1 0 0 0
E3805 Genitourinary E3805 ECOG AC
1 0.5 0 0 Cancer Control credit for QOL
E4201 Other E4201 ECOG CL 12/15/2005 1 0.3 0 0 0.3 Cancer Control credit for QOL component
E4402 Lymphomas Non-Hodgkin's E4402 ECOG AC
1 0.5 0 0 No CC Credit because NO QOL component in original protocol; QOL component added via Amend #2 (12/03/2004) and approved for 0.5 cancer control credit.
E4599 Lung Non-Small Cell E4599 ECOG CL 4/7/2004 1
0 0
E4A03 Other E4A03 ECOG CL 3/30/2006 1
0 0
E5103 Breast E5103 ECOG AC
1 0 0 0
E5202 Gastrointestinal E5202 ECOG AC
1 0 0 0 NOTE: Arm A and B are assiged 1.0 Treatment Credit while Arm C is assigned 0.5 Treatment Credit.
E5202-ARM-C Gastrointestinal E5202-ARM-C ECOG AC
0.5 0 0 0
E5204 Gastrointestinal E5204 ECOG AC
1 0.5 0 0 0.5 Cancer Control for QOL on subset of Target/Planned Enrollment
E6201 Gastrointestinal E6201 ECOG CL 3/16/2005 1 0.5 0 0 0.5 Cancer Control Credit for QOL study component
E8802 Genitourinary E8802 ECOG CL 4/19/2007 1 0 0 0
EORTC-30904 Other EORTC-30904 ECOG CL 1/13/2003

0 0
GOG-0182 Gynecologic GOG-0182 GOG CL 9/1/2004 1
0 0
GOG-0198 Gynecologic GOG-0198 GOG CL 7/23/2007 1
0 0
GOG-0209 Breast GOG-0209 GOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
GOG-0218 Gynecologic GOG-0218 GOG AC
1 0.5 0 0 0.5 Cancer control credit for QOL
GOG-0219 Gynecologic GOG-0219 GOG AC
1 0 0 0
IBCSG-24-02 Breast IBCSG-24-02 CTSU AC
1 0.5 0 0 0.5 Cancer Control Credit for QOL
IBCSG-25-02 Breast IBCSG-25-02 CTSU CL 11/30/2007 1 0.5 0 0 0.5 Cancer Control Credit for QOL
IBCSG-26-02 Breast
CTSU CL 11/22/2005 1 0.5 0 0 0.5 Cancer Control Credit for QOL
JPR.7 Genitourinary JPR.7 SWOG CL 11/30/2005 1 0.5 0 0 0.5 CC CREDIT FOR QOL
MDA-3410 Genitourinary MDA-3410 MDA AC
1
0 0
N0147 Gastrointestinal N0147 NCCTG AC
1 0.5 0 0
N0574 Brain N0574 NCCTG AC
1 0.5 0 0 0.5 Cancer Control for QOL component
N063D Breast N063D NCCTG AC
1 0 0 0
N06C6 Other
NCCTG AC
0 1 0 0
NCCTG-97-24-51 Lung Non-Small Cell NCCTG-97-24-51 NCCTG CL 1/8/2004 1 0.5 0 0 0.5 CC Credit is for QOL component of protocol
NCIC-BR.19 Lung Non-Small Cell NCIC-BR.19 CTSU CL 4/22/2005 1 0 0 0
NCIC-MA.20 Breast NCIC-MA.20 CTSU CL 2/2/2007 1 0 0 0 No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the study
NCIC-MA.21 Breast NCIC-MA.21 CTSU CL 4/29/2005 1 0 0 0 No Credit for QOL since CTSU sites (including CCOPs) will not participate in this component of the trial
NCIC-MA.27 Breast NCIC-MA.27 CTSU AC
1 0 0 0
NSABP B-36 Breast NSABP B-36 NSABP AC
1 0.5 0 0 0.5 Cancer Control credit for QOL; NOTE: QOL component of study closed to accrual as of 8/01/2006.
NSABP-B-30 Breast NSABP-B-30 NSABP CL 3/31/2004 1 0.5 0 0 0.5 CC Credit for QOL
NSABP-B-33 Breast NSABP-B-33 NSABP CL 10/9/2003 1 0.5 0 0
NSABP-B-34 Breast NSABP B-34 NSABP CL 3/31/2004 1.2
0 0
NSABP-B-35 Breast NSABP-B-35 NSABP CL 6/15/2006 1.1 0.3 0 0 Cancer Control Credit for QOL
NSABP-B-37 Breast NSABP-B-37 NSABP AC
1 0.5 0 0 CC credit for QOL
NSABP-B-38 Breast NSABP-B-38 NSABP CL 5/3/2007 1
0 0
NSABP-B-39 Breast NSABP-B-39 NSABP AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
NSABP-B-40 Breast NSABP-B-40 NSABP AC
1 0 0 0
NSABP-B-42 Breast NSABP-B-42 NSABP AC
1 0 0 0
NSABP-C-08 Gastrointestinal NSABP-C-08 NSABP CL 10/6/2006 1
0 0
NSABP-C-09 Gastrointestinal NSABP-C-09 NSABP CL 10/12/2007 1 0.5 0 0 0.5 Cancer Control credit for QOL
NSABP-R-04 Gastrointestinal NSABP-R-04 NSABP AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
PACCT-1 Breast PACCT-1 ECOG AC
1 0 0 0 Arm B and C receive 1.0 Treatment credit. Arm A receives 0.3 Treatment credit and Arm D receives NO credit.
PACCT-1-ARM-A Breast PACCT-1-ARM-A ECOG AC
0.3 0 0 0 Arm B and C receive 1.0 Treatment credit. Arm A receives 0.3 Treatment credit and Arm D receives NO credit.
PACCT-1-ARM-D Breast PACCT-1-ARM-D ECOG AC
0 0 0 0 Arm B and C receive 1.0 Treatment credit. Arm A receives 0.3 Treatment credit and Arm D receives NO credit.
RTOG-0214 Lung Non-Small Cell RTOG-0214 RTOG CL 8/30/2007 1 0.5 0 0 0.5 CC Credit is for QOL
RTOG-0232 Genitourinary RTOG-0232 RTOG AC
1 0.5 0 0 Cancer Control credit for QOL
RTOG-0412-SWOG-S0332 Lung Non-Small Cell RTOG-0412-SWOG-S0332 RTOG CL 12/15/2006 1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-0415 Genitourinary RTOG-0415 RTOG AC
1 0.5 0 0 0.5 Cancer Control credit is for QOL
RTOG-0421 Head and Neck RTOG-0421 RTOG CL 1/5/2007 1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-0521 Genitourinary RTOG-0521 RTOG AC
1 0 0 0
RTOG-0522 Head and Neck RTOG-0522 RTOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-0524 Genitourinary RTOG-0524 RTOG AC
1 0 0 0
RTOG-0534 Genitourinary RTOG-0534 RTOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL N= 400 patients
RTOG-0617 Lung Non-Small Cell RTOG-0617 RTOG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
RTOG-96-01 Genitourinary RTOG-96-01 RTOG CL 2/28/2003 1
0 0
RTOG-98-04 Breast RTOG 98-04 RTOG CL 7/14/2006 1
0